{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:02:50Z","timestamp":1793026970177,"version":"4.5.0"},"reference-count":102,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Children with congenital heart disease (CHD) are at substantially increased risk for respiratory infections, which occur more frequently and with greater severity than in healthy peers. This heightened vulnerability stems from multifactorial immune impairment, including defects in innate and adaptive immunity, chronic inflammation related to abnormal hemodynamics and hypoxia, reduced thymic function, and genetic syndromes affecting both cardiac and immune development. Viral pathogens\u2014particularly respiratory syncytial virus (RSV), influenza viruses, and SARS-CoV-2\u2014account for most infections, although bacterial pathogens remain relevant, especially in postoperative settings. Methods: This narrative review summarizes current evidence on infection susceptibility in children with CHD, the epidemiology and clinical relevance of major respiratory pathogens, and the effectiveness of available preventive measures. Literature evaluating immunological mechanisms, infection burden, vaccine effectiveness, and passive immunization strategies was examined, along with existing national and international immunization guidelines. Results: Children with CHD consistently exhibit higher rates of hospitalization, intensive care unit admission, mechanical ventilation, and mortality following respiratory infections. RSV, influenza, and SARS-CoV-2 infections are particularly severe in this population, while bacterial infections, though less common, contribute substantially to postoperative morbidity. Preventive options\u2014including routine childhood vaccines, pneumococcal and Haemophilus influenzae type b vaccines, influenza vaccines, COVID-19 mRNA vaccines, and RSV monoclonal antibodies\u2014demonstrate strong protective effects. New long-acting RSV monoclonal antibodies and maternal vaccination markedly enhance prevention in early infancy. However, vaccine coverage remains insufficient due to parental hesitancy, provider uncertainty, delayed immunization, and limited CHD-specific evidence. Conclusions: Respiratory infections pose a significant and preventable health burden in children with CHD. Enhancing the use of both active and passive immunization is essential to reduce morbidity and mortality. Strengthening evidence-based guidelines, improving coordination between specialists and primary care providers, integrating immunization checks into routine CHD management, and providing clear, condition-specific counseling to families can substantially improve vaccine uptake and clinical outcomes in this vulnerable population.<\/jats:p>","DOI":"10.3390\/vaccines14010011","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T07:01:33Z","timestamp":1766386893000},"page":"11","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevention of Respiratory Infections in Children with Congenital Heart Disease: Current Evidence and Clinical Strategies"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4103-2837","authenticated-orcid":false,"given":"Susanna","family":"Esposito","sequence":"first","affiliation":[{"name":"Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Aurelio","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cifaldi","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lazzara","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Viafora","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3468-5568","authenticated-orcid":false,"given":"Nicola","family":"Principi","sequence":"additional","affiliation":[{"name":"Universit\u00e0 degli Studi di Milano, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/01.CIR.43.3.323","article-title":"Congenital heart disease in 56,109 births. Incidence and natural history","volume":"43","author":"Mitchell","year":"1971","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1002\/mco2.631","article-title":"Congenital heart disease: Types, pathophysiology, diagnosis, and treatment options","volume":"5","author":"Meng","year":"2024","journal-title":"MedComm (2020)"},{"key":"ref_3","unstructured":"Centers for Disease Prevention and Control (2025, November 01). Clinical Screening and Diagnosis for Critical Congenital Heart Defects, Available online: https:\/\/www.cdc.gov\/heart-defects\/hcp\/screening\/index.html."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101776","DOI":"10.1016\/j.ppedcard.2024.101776","article-title":"Consequences and complications of un-intervened congenital heart defects in children: A retrospective cross-sectional study","volume":"76","author":"Gelaw","year":"2025","journal-title":"Prog. Pediatr. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lee, J., Marshall, T., Buck, H., Pamela, M., and Daack-Hirsch, S. (2025). Growth Failure in Children with Congenital Heart Disease. Children, 12.","DOI":"10.3390\/children12050616"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pedneo.2012.07.006","article-title":"The impact of patent ductus arteriosus in neonates with late onset sepsis: A retrospective matched-case control study","volume":"53","author":"Chiang","year":"2012","journal-title":"Pediatr. Neonatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00246-016-1473-9","article-title":"Incidence of Respiratory Disease During the First Two Years of Life in Children with Hemodynamically Significant Congenital Heart Disease in Italy: A Retrospective Study","volume":"37","author":"Pongiglione","year":"2016","journal-title":"Pediatr. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1017\/S1047951120004333","article-title":"Acute respiratory infections in hospitalized infants with congenital heart disease","volume":"31","author":"Ahuja","year":"2021","journal-title":"Cardiol. Young"},{"key":"ref_9","first-page":"883","article-title":"Polymorphonuclear leukocyte functions in children with cyanotic and acyanotic congenital heart disease","volume":"30","author":"Parikh","year":"1993","journal-title":"Indian Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s00246-021-02681-3","article-title":"Neutrophil and T Cell Functions in Patients with Congenital Heart Diseases: A Review","volume":"42","author":"Yuki","year":"2021","journal-title":"Pediatr. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpeds.2019.05.061","article-title":"T-Cell Receptor Excision Circles in Newborns with Congenital Heart Disease","volume":"213","author":"Davey","year":"2019","journal-title":"J. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.5114\/ceji.2014.47734","article-title":"Cellular immunity profile in children with congenital heart disease and bronchopneumonia: Evaluation of lymphocyte subsets and regulatory T cells","volume":"4","author":"Huang","year":"2014","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_13","first-page":"83","article-title":"The Role of Immune Markers in Predicting Infectious Complications in Children with Congenital Heart Defects","volume":"22","author":"Elena","year":"2025","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Rouatbi, H., Farhat, N., Heying, R., G\u00e9rard, A., Vazquez-Jimenez, J.F., and Seghaye, M.-C. (2020). Right Atrial Myocardial Remodeling in Children with Atrial Septal Defect Involves Inflammation, Growth, Fibrosis, and Apoptosis. Front. Pediatr., 8.","DOI":"10.3389\/fped.2020.00040"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/j.ijcard.2013.12.091","article-title":"Neurohormones, cytokines, and aortic function in children with repaired coarctation of the aorta","volume":"172","author":"Moutafi","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s00246-013-0715-3","article-title":"Inflammatory markers are elevated in Eisenmenger syndrome","volume":"34","author":"Ramakrishnan","year":"2013","journal-title":"Pediatr. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1002\/imt2.144","article-title":"From heart to gut: Exploring the gut microbiome in congenital heart disease","volume":"2","author":"Liu","year":"2023","journal-title":"iMeta"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Zhang, Q.-L., Chen, X.-H., Zhou, S.-J., Lei, Y.-Q., Huang, J.-S., Chen, Q., and Cao, H. (2023). Relationship between disorders of the intestinal microbiota and heart failure in infants with congenital heart disease. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1152349"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s10741-021-10187-6","article-title":"Immunity and inflammation: The neglected key players in congenital heart disease?","volume":"27","author":"Wienecke","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.2741\/4869","article-title":"Role of reactive oxygen species and iron in host defense against infection","volume":"25","author":"Dickson","year":"2020","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Cavalcanti, N.V., Palmeira, P., Jatene, M.B., Dorna, M.d.B., and Carneiro-Sampaio, M. (2021). Early Thymectomy Is Associated with Long-Term Impairment of the Immune System: A Systematic Review. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.774780"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10875-024-01662-4","article-title":"Thymic Atrophy and Immune Dysregulation in Infants with Complex Congenital Heart Disease","volume":"44","author":"Bremer","year":"2024","journal-title":"J. Clin. Immunol."},{"key":"ref_24","first-page":"e20250190","article-title":"The systemic effects of 22q11.2 deletion syndrome on immunity","volume":"2","author":"Sullivan","year":"2025","journal-title":"J. Hum. Immun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clicom.2025.09.001","article-title":"Immunologic profiles and infection patterns in patients with down syndrome: A retrospective review","volume":"8","author":"Satnarine","year":"2025","journal-title":"Clin. Immunol. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.122.059706","article-title":"Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus","volume":"147","author":"Dimopoulos","year":"2023","journal-title":"Circulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"107012","DOI":"10.1016\/j.isci.2023.107012","article-title":"Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling","volume":"26","author":"Chi","year":"2023","journal-title":"iScience"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4161\/org.4.2.5851","article-title":"Wnt signal transduction pathways","volume":"4","author":"Komiya","year":"2008","journal-title":"Organogenesis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.2147\/JIR.S280953","article-title":"Interferon-Driven Immune Dysregulation in Down Syndrome: A Review of the Evidence","volume":"14","author":"Chung","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Huang, A.C., Olson, S.B., and Maslen, C.L. (2021). A Review of Recent Developments in Turner Syndrome Research. J. Cardiovasc. Dev. Dis., 8.","DOI":"10.3390\/jcdd8110138"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11882-016-0612-y","article-title":"Epigenetic Dysfunction in Turner Syndrome Immune Cells","volume":"16","author":"Thrasher","year":"2016","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJM198208123070702","article-title":"Respiratory syncytial viral infection in infants with congenital heart disease","volume":"307","author":"MacDonald","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0022-3476(05)90000-0","article-title":"Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada","volume":"121","author":"Navas","year":"1992","journal-title":"J. Pediatr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/00003246-199210000-00008","article-title":"Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: A recent experience","volume":"20","author":"Moler","year":"1992","journal-title":"Crit. Care Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1097\/00003246-199909000-00042","article-title":"Impact of respiratory syncytial virus infection on surgery for congenital heart disease: Postoperative course and outcome","volume":"27","author":"Khongphatthanayothin","year":"1999","journal-title":"Crit. Care Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40121-016-0142-x","article-title":"Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease","volume":"6","author":"Checchia","year":"2017","journal-title":"Infect. Dis. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S613","DOI":"10.1093\/infdis\/jiz150","article-title":"Acute Lower Respiratory Infections Associated with Respiratory Syncytial Virus in Children with Underlying Congenital Heart Disease: Systematic Review and Meta-analysis","volume":"222","author":"Chaw","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/adc.2003.046714","article-title":"Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease","volume":"89","author":"Duppenthaler","year":"2004","journal-title":"Arch. Dis. Child."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Fjaerli, H.-O., Farstad, T., and Bratlid, D. (2004). Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993\u20132000: A population-based retrospective study. BMC Pediatr., 4.","DOI":"10.1186\/1471-2431-4-25"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.15585\/mmwr.mm7436a2","article-title":"Influenza-Associated Pediatric Deaths\u2014United States, 2024-25 Influenza Season","volume":"74","author":"Reinhart","year":"2025","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14787210.2016.1227701","article-title":"Severe influenza in children: Incidence and risk factors","volume":"14","author":"Principi","year":"2016","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ghimire, L.V., Chou, F.-S., and Moon-Grady, A.J. (2020). Impact of congenital heart disease on outcomes among pediatric patients hospitalized for influenza infection. BMC Pediatr., 20.","DOI":"10.1186\/s12887-020-02344-x"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1007\/s00246-024-03613-7","article-title":"Congenital Heart Defects and Concurrent Diagnoses in Influenza Hospitalization in the Pediatric Health Information System Study, 2004\u20132019","volume":"46","author":"Stephens","year":"2025","journal-title":"Pediatr. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jpids\/piaa074","article-title":"The Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Healthcare Network in the United States","volume":"9","author":"Otto","year":"2020","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12519-023-00790-y","article-title":"Severe pediatric COVID-19: A review from the clinical and immunopathophysiological perspectives","volume":"20","author":"Sun","year":"2024","journal-title":"World J. Pediatr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.arcped.2021.07.004","article-title":"COVID-19 hospitalization rate in children across a private hospital network in the United States: COVID-19 hospitalization rate in children","volume":"28","author":"Kim","year":"2021","journal-title":"Arch. Pediatr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/apc.apc_134_21","article-title":"Outcome of COVID-19-positive children with heart disease and grown-ups with congenital heart disease: A multicentric study from India","volume":"14","author":"Sachdeva","year":"2021","journal-title":"Ann. Pediatr. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/heartjnl-2020-318467","article-title":"Clinical outcome of COVID-19 in patients with adult congenital heart disease","volume":"107","author":"Schwerzmann","year":"2021","journal-title":"Heart"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jpeds.2020.07.069","article-title":"Coronavirus Disease 2019 Infection in Children with Pre-Existing Heart Disease","volume":"227","author":"Simpson","year":"2020","journal-title":"J. Pediatr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"A4370357","DOI":"10.1161\/circ.152.suppl_3.4370357","article-title":"Abstract 4370357: Effect of COVID-19 on Pediatric Population and Congenital Heart Disease: A Comprehensive Examination of Outcomes, Vaccination Effectiveness, and Healthcare Inequalities","volume":"152","author":"Madkour","year":"2025","journal-title":"Circulation"},{"key":"ref_51","first-page":"270","article-title":"Pneumococcal Conjugate Vaccine and Pneumonia Prevention in Children with Congenital Heart Disease","volume":"69","year":"2017","journal-title":"Rev. Investig. Clin."},{"key":"ref_52","first-page":"554","article-title":"Postoperative nosocomial infections among children with congenital heart disease","volume":"30","author":"Zhang","year":"2014","journal-title":"Pak. J. Med. Sci."},{"key":"ref_53","first-page":"484","article-title":"The identification and vaccination status of children with CHD at a community health care center in Shenzhen","volume":"11","author":"Jiang","year":"2017","journal-title":"J. Dis. Monit. Control"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1080\/21645515.2021.1872343","article-title":"Reasons of the delayed vaccination, recommendations and safety of vaccination in children with congenital heart disease in Zhejiang, China","volume":"17","author":"Li","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.15386\/mpr-2814","article-title":"Addressing immunization gaps in children with congenital heart disease\u2014A narrative review","volume":"98","author":"Filip","year":"2025","journal-title":"Med. Pharm. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1038\/s41390-022-02344-w","article-title":"Vaccination in children with congenital heart disease: An observational study in a Beijing hospital","volume":"93","author":"Zhou","year":"2023","journal-title":"Pediatr. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cjcpc.2021.12.003","article-title":"A Survey of Immunization Practices in Patients with Congenital Heart Disease","volume":"1","author":"Sanatani","year":"2022","journal-title":"CJC Pediatr. Congenit. Heart Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"IMpact-RSV Study Group (1998). Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics, 102, 531\u2013537.","DOI":"10.1542\/peds.102.3.531"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease","volume":"143","author":"Feltes","year":"2003","journal-title":"J. Pediatr."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/DHPS.S348727","article-title":"Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease","volume":"15","author":"Galway","year":"2023","journal-title":"Drug Healthc. Patient Saf."},{"key":"ref_62","first-page":"46","article-title":"A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis","volume":"16","author":"Frogel","year":"2010","journal-title":"J. Manag. Care Pharm."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1067\/mpd.2000.110531","article-title":"Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid","volume":"137","author":"Boyce","year":"2000","journal-title":"J. Pediatr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/chd.12590","article-title":"RSV prophylaxis guideline changes and outcomes in children with congenital heart disease","volume":"13","author":"Walpert","year":"2018","journal-title":"Congenit. Heart Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e2023061803","DOI":"10.1542\/peds.2023-061803","article-title":"Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection","volume":"152","author":"Caserta","year":"2023","journal-title":"Pediatrics"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/14787210.2025.2481908","article-title":"Twenty-five years of palivizumab: A global historic review of its impact on the burden of respiratory syncytial virus disease in children","volume":"23","author":"Bont","year":"2025","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2352-4642(22)00321-2","article-title":"Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: A pooled analysis of randomised controlled trials","volume":"7","author":"Madhi","year":"2023","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S2352-4642(25)00102-6","article-title":"180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): A randomised, controlled, phase 3b trial","volume":"9","author":"Munro","year":"2025","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/jpids\/piad052","article-title":"Safety of Re-dosing Nirsevimab Prior to RSV Season 2 in Children with Heart or Lung Disease","volume":"12","author":"Domachowske","year":"2023","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJMoa2502984","article-title":"Clesrovimab for Prevention of RSV Disease in Healthy Infants","volume":"393","author":"Zar","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Committee on Infectious Diseases (2025). Recommendations for the Prevention of RSV Disease in Infants and Children: Policy Statement. Pediatrics, 156, e2025073923.","DOI":"10.1542\/peds.2025-073923"},{"key":"ref_72","first-page":"102986","article-title":"Acceptance and safety of the RSV-preventive treatment of newborns with nirsevimab in the maternity department: A prospective longitudinal cohort study in France","volume":"79","author":"Testard","year":"2024","journal-title":"eClinicalMedicine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S1473-3099(25)00156-2","article-title":"Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): A multicentre, retrospective, test-negative, case\u2013control study","volume":"25","author":"Marc","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Principi, N., Perrone, S., and Esposito, S. (2025). Challenges and Limitations of Current RSV Prevention Strategies in Infants and Young Children: A Narrative Review. Vaccines, 13.","DOI":"10.3390\/vaccines13070717"},{"key":"ref_75","unstructured":"World Health Organization (2025, November 05). WHO Recommendations for Routine Immunization. Summary Tables. Available online: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/policies\/who-recommendations-for-routine-immunization---summary-tables."},{"key":"ref_76","unstructured":"European Center for Disease Prevention and Control (2025, November 05). Vaccine Scheduler. Available online: https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=15&SelectedCountryIdByDisease=-1."},{"key":"ref_77","first-page":"CD004879","article-title":"Vaccines for preventing influenza in healthy children","volume":"2","author":"Jefferson","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.amepre.2016.02.027","article-title":"Cost effectiveness of influenza vaccine for U.S. children","volume":"51","author":"Shim","year":"2016","journal-title":"Am. J. Prev. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S2352-4642(23)00225-0","article-title":"Effectiveness of the quadrivalent live attenuated influenza vaccine against influenza-related hospitalisations and morbidity among children aged 2 to 6 years in Denmark: A nationwide cohort study emulating a target trial","volume":"7","author":"Kildegaard","year":"2023","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/cid\/ciab270","article-title":"Effectiveness of influenza vaccination in preventing hospitalization due to influenza in children: A systematic review and meta-analysis","volume":"73","author":"Boddington","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.amjcard.2017.11.008","article-title":"Frequency and Consequences of Influenza Vaccination in Adults with Congenital Heart Disease","volume":"121","author":"Bare","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/jpc.15748","article-title":"Influenza vaccination among caregivers and household contacts of children with congenital heart disease before and during COVID-19 pandemic","volume":"58","author":"Gkentzi","year":"2022","journal-title":"J. Paediatr. Child Health"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1097\/INF.0000000000001579","article-title":"Influenza Vaccination Rate and Reasons for Nonvaccination in Children with Cardiac Disease","volume":"36","author":"Livni","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_84","first-page":"1472","article-title":"Influenza Vaccination in Patients with Congenital Heart Disease in the Pre-COVID-19 Era: Coverage Rate, Patient Characteristics, and Outcomes","volume":"37","author":"Moons","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2667033","DOI":"10.1155\/2024\/2667033","article-title":"COVID-19 Vaccines in the Pediatric Population: A Focus on Cardiac Patients","volume":"2024","author":"Lababidi","year":"2024","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamapediatrics.2023.4505","article-title":"Effectiveness of Monovalent mRNA Vaccines Against Omicron XBB Infection in Singaporean Children Younger Than 5 Years","volume":"177","author":"Wee","year":"2023","journal-title":"JAMA Pediatr."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Watanabe, A., Kani, R., Iwagami, M., Takagi, H., Yasuhara, J., and Kuno, T. (2023). Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review and Meta-analysis. JAMA Pediatr., 177, 384\u2013394.","DOI":"10.1001\/jamapediatrics.2022.6243"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1007\/s00431-023-05216-5","article-title":"Effectiveness of COVID-19 vaccines among children and adolescents against SARS-CoV-2 variants: A meta-analysis","volume":"182","author":"Lan","year":"2023","journal-title":"Eur. J. Pediatr."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa2117995","article-title":"Effectiveness of BNT162b2 vaccine against critical covid-19 in adolescents","volume":"386","author":"Olson","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e2023064446","DOI":"10.1542\/peds.2023-064446","article-title":"Vaccine Effectiveness Against Long COVID in Children","volume":"153","author":"Razzaghi","year":"2024","journal-title":"Pediatrics"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2573562","DOI":"10.1080\/21645515.2025.2573562","article-title":"Understanding public confidence in locally-produced mRNA vaccines: Insights for future pandemic preparedness","volume":"21","author":"Wong","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_92","unstructured":"Australian Government (2025, November 05). Healthy Infants, Children and Adolescents Aged <18 Years Are Not Recommended to Receive COVID-19 Vaccine, Available online: https:\/\/immunisationhandbook.health.gov.au\/recommendations\/healthy-infants-children-and-adolescents-aged#:~:text=COVID%2D19%20vaccine%20is%20not,to%20outweigh%20the%20potential%20harms."},{"key":"ref_93","unstructured":"(2025, November 05). Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/covid\/hcp\/vaccine-considerations\/routine-guidance.html#:~:text=At%20a%20glance,of%20COVID%2D19%20risk%20factors."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"427","DOI":"10.32604\/CHD.2021.016713","article-title":"COVID-19 Vaccine Priority Access for Adults and Children with Congenital Heart Disease: A Statement of the Italian Society of Pediatric Cardiology","volume":"16","author":"Assenza","year":"2021","journal-title":"Congenit. Heart Dis."},{"key":"ref_95","unstructured":"Centers for Disease Control and Prevention (2025, November 05). COVID-19 Vaccination Coverage and Intent for Vaccination, Children 6 Months Through 17 Years, United States, Available online: https:\/\/www.cdc.gov\/covidvaxview\/weekly-dashboard\/child-coverage-vaccination.html."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1038\/s41467-024-46451-0","article-title":"Uptake of COVID-19 vaccinations amongst 3,433,483 children and young people: Meta-analysis of UK prospective cohorts","volume":"15","author":"Aldridge","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/heartjnl-2024-324470","article-title":"CVD-COVID-UK\/COVID-IMPACT consortium. The impact of COVID-19 vaccination on patients with congenital heart disease in England: A case-control study","volume":"110","author":"Harrison","year":"2024","journal-title":"Heart"},{"key":"ref_98","first-page":"7601185","article-title":"Epidemiologic Characteristics of Adolescents with COVID-19 Disease with Acute Hypoxemic Respiratory Failure","volume":"2022","author":"Kest","year":"2022","journal-title":"Crit. Care Res. Pract."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Principi, N., and Esposito, S. (2021). Pneumococcal Disease Prevention: Are We on the Right Track?. Vaccines, 9.","DOI":"10.3390\/vaccines9040305"},{"key":"ref_100","unstructured":"(2025, November 05). European Center for Disease Prevention and Control. Available online: https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByCountry?SelectedCountryId=46&IncludeChildAgeGroup=true&IncludeAdultAge-Group=true&SelectedVersionId=1192#:~:text=*%20MMR%20is%20recommended%20at%20the%20age,those%20not%20been%20vaccinated%20earlier%20was%20removed."},{"key":"ref_101","unstructured":"Centers for Disease Control and Prevention (2025, November 05). Summary of Risk-Based Pneumococcal Vaccination Recommendations, Available online: https:\/\/www.cdc.gov\/pneumococcal\/hcp\/vaccine-recommendations\/risk-indications.html#:~:text=Give%201%20dose%20of%20PCV20%20or%20PPSV23%20at%20least%208,Their%20pneumococcal%20vaccinations%20are%20complete."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.pedhc.2023.05.008","article-title":"Pneumococcal Pure Polysaccharide Vaccination in Pediatric Patients with Chronic Heart Disease","volume":"37","author":"Seazzu","year":"2023","journal-title":"J. Pediatr. Health Care"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/1\/11\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T07:17:04Z","timestamp":1766387824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/1\/11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["vaccines14010011"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14010011","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]}}}